Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of centrally acting agents targeting neurological disorders. Its structural framework supports the creation of compounds with activity on neurotransmitter receptors, making it valuable in research for antidepressants and cognitive enhancers. The compound's rigid polycyclic structure aids in improving selectivity and binding affinity in drug candidates. It is also employed in medicinal chemistry for scaffold modification studies aimed at optimizing pharmacokinetic properties.